Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.
Klemann C,Esquivel M,Magerus-Chatinet A,Lorenz M,Fuchs I,Neveux N,Castelle M,Rohr J,da Cunha C,Ebinger M,Kobbe R,Kremens B,Kollert F,Gambineri E,Lehmberg K,Seidel M,Siepermann K,Voelker T,Schuster V,Goldacker S,Schwarz K,Speckmann C,Picard C,Fischer A,Rieux-Laucat F,Ehl S,Rensing-Ehl A,Neven B
Source :
Haematologica
2016 Oct 28
Pmid / DOI:
27789675